Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Kane Biotech Inc KNBIF


Primary Symbol: V.KNE

Healthcare Biotechnology
Kane Biotech Inc. is a Canada-based biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The Company has a portfolio of biotechnologies, intellectual property (66 patents and patents pending, trade secrets and trademarks) and products developed by its own biofilm research expertise and acquired... see more

Recent & Breaking News (TSXV:KNE)

Kane Biotech to Release Fourth Quarter and Full Year 2021 Financial Results on March 24 - Conference Call to Follow

GlobeNewswire March 17, 2022

Kane Biotech (TSXV:KNE) announces $1M private placement

Trevor Abes  March 15, 2022

Kane Biotech Announces Private Placement Offering

GlobeNewswire March 15, 2022

Kane Biotech (TSXV:KNE) partners with universities for DispersinB study

Caroline Egan  February 10, 2022

Kane Biotech Announces New Collaboration Agreements for Prosthetic Joint Infection, expanding its DispersinB® applications

GlobeNewswire February 10, 2022

Kane Biotech (TSXV:KNE) wound care commercialization to be a key focus in 2022

Brieanna McCutcheon  January 20, 2022

Wound Care Commercialization to be a Key Company Focus in 2022

GlobeNewswire January 20, 2022

Kane Biotech Announces Third Quarter 2021 Financial Results

GlobeNewswire November 16, 2021

Kane Biotech to Release Third Quarter 2021 Financial Results on November 16 - Conference Call to Follow

GlobeNewswire November 9, 2021

Kane Biotech (TSXV:KNE) amends credit facility agreement

Brieanna McCutcheon  September 2, 2021

Kane Biotech Announces New Credit Facility

GlobeNewswire September 2, 2021

STEM Animal Health completes first shipment of bluestem(TM) oral care products to PetSmart® Canada

GlobeNewswire August 31, 2021

Kane Biotech Announces Second Quarter 2021 Financial Results

GlobeNewswire August 26, 2021

Kane Biotech to Release Second Quarter 2021 Financial Results on August 26 - Conference Call to Follow

GlobeNewswire August 19, 2021

Kane Biotech (TSXV:KNE) receives two European patents

Trevor Abes  July 29, 2021

Kane Biotech Receives Decisions to Grant for Two European Patents Providing Broad Protection of coactiv+(TM) Technology for Wound Care, Skin Infections and Personal Care Formulations

GlobeNewswire July 29, 2021

Kane Biotech Expands its Wound Care and Surgical Portfolio with a coactiv+TM Antimicrobial Hydrogel

GlobeNewswire July 22, 2021

Kane Biotech Announces Cancellation of Options and Issuance of Restricted Share Units

GlobeNewswire July 21, 2021

Kane Biotech announces two key milestones as DispersinB® wound care project advances towards human clinical trials

GlobeNewswire July 13, 2021

Kane Biotech to meet investors at Whistler 2021 Capital Conference

GlobeNewswire June 29, 2021